These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26138800)

  • 1. PITER: An ongoing nationwide study on the real-life impact of direct acting antiviral based treatment for chronic hepatitis C in Italy.
    Kondili LA; Vella S;
    Dig Liver Dis; 2015 Sep; 47(9):741-3. PubMed ID: 26138800
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic Hepatitis C: a smart coat over a ragged dress?
    Gaeta GB
    Dig Liver Dis; 2009 Jul; 41(7):465-6. PubMed ID: 19410521
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct-acting antiviral agents for the treatment of HCV.
    Thompson AJ; Locarnini S
    Antivir Ther; 2012; 17(6 Pt B):1105-7. PubMed ID: 23188736
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral agents and hepatitis C.
    Archer-Festa M; Nilsen-Kupsch S
    N Y State Dent J; 2012; 78(4):42-5. PubMed ID: 23252194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Q & A with Karen Tashima, MD new direct-acting antiviral agents offer therapeutic revolution for hepatitis C virus infection.
    Korr M
    R I Med J (2013); 2014 Jul; 97(7):29-30. PubMed ID: 24983018
    [No Abstract]   [Full Text] [Related]  

  • 6. [New strategies for treatment of chronic hepatitis C].
    Rizzetto M
    Forum (Genova); 1999; 9(2 Suppl):1-11. PubMed ID: 11300125
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic hepatitis C in children: natural history and prognosis].
    Bortolotti F
    Recenti Prog Med; 2009 Feb; 100(2):97-102. PubMed ID: 19350803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Will hepatitis C be eradicated in France by 2025?].
    Nau JY
    Rev Med Suisse; 2015 Jun; 11(478):1316-7. PubMed ID: 26211093
    [No Abstract]   [Full Text] [Related]  

  • 9. The end of hepatitis C.
    Sussman NL; Remien CH; Kanwal F
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):533-6. PubMed ID: 24480676
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis C and B (HCV, HBV)].
    Violante MD
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():101-3. PubMed ID: 17037789
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study.
    Gramenzi A; Conti F; Felline F; Cursaro C; Riili A; Salerno M; Gitto S; Micco L; Scuteri A; Andreone P; Bernardi M
    J Viral Hepat; 2010 May; 17(5):360-6. PubMed ID: 19758274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AISF position paper on HCV in immunocompromised patients.
    Italian Association for the Study of the Liver (AISF)
    Dig Liver Dis; 2019 Jan; 51(1):10-23. PubMed ID: 30366813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs.
    Mishra P; Murray J; Birnkrant D
    Hepatology; 2015 Oct; 62(4):1298-303. PubMed ID: 25953139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions.
    Douglas SD
    Brain Behav Immun; 2005 Jan; 19(1):20-2. PubMed ID: 15581734
    [No Abstract]   [Full Text] [Related]  

  • 16. [A French prospective observational study of the treatment of chronic hepatitis C in drug abusers: a commentary].
    Michel L; Roux P; Cohen J; Carrieri MP
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):15-6; author reply 16-7. PubMed ID: 19084361
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C.
    Bickerstaff C
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):787-800. PubMed ID: 26289734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.
    Fernández-Yunquera A; Rincón D; Salcedo M; Bañares R
    Rev Esp Quimioter; 2013 Sep; 26(3):189-92. PubMed ID: 24080883
    [No Abstract]   [Full Text] [Related]  

  • 19. Ribavirin treatment in patients with chronic hepatitis C infection who had renal transplantation.
    Karaca C; Besisik F; Akyuz F; Dincer D; Sever MS; Okten A
    Dig Surg; 2005; 22(1-2):113. PubMed ID: 15849473
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C.
    Vukotic R; Gamal N; Andreone P
    Dig Liver Dis; 2015 Feb; 47(2):151-6. PubMed ID: 25483909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.